Meena Thayu

3.6k total citations
59 papers, 2.0k citations indexed

About

Meena Thayu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Meena Thayu has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Meena Thayu's work include Lung Cancer Treatments and Mutations (22 papers), Microscopic Colitis (14 papers) and Inflammatory Bowel Disease (14 papers). Meena Thayu is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Microscopic Colitis (14 papers) and Inflammatory Bowel Disease (14 papers). Meena Thayu collaborates with scholars based in United States, South Korea and Spain. Meena Thayu's co-authors include Mary B. Leonard, Babette S. Zemel, Justine Shults, Robert N. Baldassano, Jon M. Burnham, Rita Herskovitz, Roland E. Knoblauch, Byoung Chul Cho, Lee A. Denson and Petar Mamula and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Meena Thayu

56 papers receiving 2.0k citations

Peers

Meena Thayu
Neelam Varma India
Wolfgang Arns Germany
Barbara M. Ryan Ireland
Evarist Feliú Spain
Ulla M. Saarinen‐Pihkala Finland
Sally Killick United Kingdom
Joseph Mirro United States
C Nissen Switzerland
Maureen Reiner United States
Yasuo Hirai Japan
Neelam Varma India
Meena Thayu
Citations per year, relative to Meena Thayu Meena Thayu (= 1×) peers Neelam Varma

Countries citing papers authored by Meena Thayu

Since Specialization
Citations

This map shows the geographic impact of Meena Thayu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meena Thayu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meena Thayu more than expected).

Fields of papers citing papers by Meena Thayu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meena Thayu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meena Thayu. The network helps show where Meena Thayu may publish in the future.

Co-authorship network of co-authors of Meena Thayu

This figure shows the co-authorship network connecting the top 25 collaborators of Meena Thayu. A scholar is included among the top collaborators of Meena Thayu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meena Thayu. Meena Thayu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haddish‐Berhane, Nahor, Alberto Russu, Meena Thayu, et al.. (2023). Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer. Clinical Pharmacology & Therapeutics. 115(3). 468–477. 5 indexed citations
3.
4.
Park, Keunchil, Joshua K. Sabari, Eric B. Haura, et al.. (2022). MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study. Annals of Oncology. 33. S482–S482. 1 indexed citations
5.
Shu, Catherine A., Keiko Goto, Yuichiro Ohe, et al.. (2021). 1193MO Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2. Annals of Oncology. 32. S952–S953. 13 indexed citations
6.
Cho, Byoung Chul, Dongwook Kim, Jin Sun Lee, et al.. (2020). 1258O Amivantamab (JNJ-61186372), an EGFR-MET bispecific antibody, in combination with lazertinib, a 3rd-generation tyrosine kinase inhibitor (TKI), in advanced EGFR NSCLC. Annals of Oncology. 31. S813–S813. 32 indexed citations
7.
Pillai, Rathi N., Suresh S. Ramalingam, Meena Thayu, et al.. (2020). Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414). JTO Clinical and Research Reports. 2(2). 100104–100104. 11 indexed citations
8.
Stein, Ronen, Dale Lee, Mary B. Leonard, et al.. (2016). Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases. 22(6). 1370–1377. 38 indexed citations
9.
Sylvester, Francisco, Catherine M. Gordon, Meena Thayu, et al.. (2013). Report of the CCFA Pediatric Bone, Growth and Muscle Health Workshop, New York City, November 11–12, 2011, With Updates. Inflammatory Bowel Diseases. 19(13). 2919–2926. 12 indexed citations
10.
Leonard, Mary B., Justine Shults, Babette S. Zemel, et al.. (2012). Changes in Vitamin D and Parathyroid Hormone Metabolism in Incident Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases. 19(1). 45–53. 26 indexed citations
11.
Pappa, Helen, Meena Thayu, Francisco Sylvester, et al.. (2011). Skeletal Health of Children and Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 53(1). 11–25. 85 indexed citations
12.
Foster, Bethany J., Heidi J. Kalkwarf, Justine Shults, et al.. (2010). Association of Chronic Kidney Disease with Muscle Deficits in Children. Journal of the American Society of Nephrology. 22(2). 377–386. 74 indexed citations
13.
Mascarenhas, Maria R. & Meena Thayu. (2010). Pediatric Inflammatory Bowel Disease and Bone Health. Nutrition in Clinical Practice. 25(4). 347–352. 6 indexed citations
14.
Thayu, Meena, Lee A. Denson, Justine Shults, et al.. (2010). Determinants of Changes in Linear Growth and Body Composition in Incident Pediatric Crohn's Disease. Gastroenterology. 139(2). 430–438. 82 indexed citations
15.
Thayu, Meena, Mary B. Leonard, Jeffrey S. Hyams, et al.. (2008). Improvement in Biomarkers of Bone Formation During Infliximab Therapy in Pediatric Crohn's Disease: Results of the REACH Study. Clinical Gastroenterology and Hepatology. 6(12). 1378–1384. 76 indexed citations
16.
Thayu, Meena, Justine Shults, Jon M. Burnham, et al.. (2007). Gender differences in body composition deficits at diagnosis in children and adolescents with Crohnʼs disease. Inflammatory Bowel Diseases. 13(9). 1121–1128. 55 indexed citations
17.
Haber, Barbara, Jessi Erlichman, Meena Thayu, Alan W. Flake, & Elizabeth B. Rand. (2006). Successful revision of portoenterostomy in an infant with biliary atresia. Journal of Pediatric Surgery. 41(7). e1–e3. 6 indexed citations
18.
Thayu, Meena, et al.. (2005). Hepatosplenic T‐Cell Lymphoma in an Adolescent Patient after Immunomodulator and Biologic Therapy for Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 40(2). 220–222. 1 indexed citations
19.
Balter, Sharon, Elizabeth R. Zell, Katherine L. O’Brien, et al.. (2003). Impact of intrapartum antibiotics on the care and evaluation of the neonate. The Pediatric Infectious Disease Journal. 22(10). 853–857. 10 indexed citations
20.
Thayu, Meena, et al.. (2003). Cardiac ischemia during hemolytic uremic syndrome. Pediatric Nephrology. 18(3). 286–289. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelam Varma Breakdown of academic impact, for papers by Wolfgang Arns Breakdown of academic impact, for papers by Barbara M. Ryan Breakdown of academic impact, for papers by Evarist Feliú Breakdown of academic impact, for papers by Ulla M. Saarinen‐Pihkala Breakdown of academic impact, for papers by Sally Killick Breakdown of academic impact, for papers by Joseph Mirro Breakdown of academic impact, for papers by C Nissen Breakdown of academic impact, for papers by Maureen Reiner Breakdown of academic impact, for papers by Yasuo Hirai
Rankless by CCL
2026